|
Court: 483 Nondisclosure Can Be Basis for Class Action Lawsuit
A class action lawsuit that used FDA Form 483 inspection reports to demonstrate that KV Pharmaceutical made false or misleading statements regarding its regulatory compliance can proceed even though inspection reports are not final agency determinations, an appeals court ruled.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives